Statement Of Cash Flows [Abstract]

Affluent Medical - Filing #2810675

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
12 054 EUR
11 081 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
171,000 EUR
146,000 EUR
Purchase of intangible assets, classified as investing activities
13,000 EUR
- EUR
Cash flows from (used in) investing activities
184,000 EUR
146,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
- EUR
- EUR
Repayments of borrowings, classified as financing activities
200,000 EUR
50,000 EUR
Payments of lease liabilities, classified as financing activities
351,000 EUR
360,000 EUR
Proceeds from government grants, classified as financing activities
- EUR
- EUR
Interest paid, classified as financing activities
67,000 EUR
183,000 EUR
Other inflows (outflows) of cash, classified as financing activities
- EUR
302,000 EUR
Cash flows from (used in) financing activities
11 316 EUR
2 401 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
- EUR
- EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
922,000 EUR
8 826 EUR
Cash and cash equivalents
1 658 EUR
2 580 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.